Literature DB >> 1907609

Detection of enterococcal high-level aminoglycoside resistance with MicroScan freeze-dried panels containing newly modified medium and Vitek Gram-Positive Susceptibility cards.

D Weissmann1, J Spargo, C Wennersten, M J Ferraro.   

Abstract

Both conventional and modified MicroScan Type 5 panels and Vitek Gram-Positive Susceptibility cards were compared with agar dilution screen plates for their abilities to detect high-level resistance to gentamicin and streptomycin in 235 enterococcal isolates, including 167 Enterococcus faecalis and 63 E. faecium isolates. The modified Type 5 panels contained dextrose-phosphate broth instead of Mueller-Hinton broth in their high-level-resistance screen wells. The sensitivities for detection of gentamicin and streptomycin high-level resistance were 100 and 100% (E. faecalis) and 100 and 94% (E. faecium) for the modified MicroScan panels, 100 and 89% (E. faecalis) and 100 and 98% (E. faecium) for the conventional MicroScan panels, and 81 and 86% (E. faecalis) and 85 and 94% (E. faecium) for the Vitek cards. All specificities were 100% except for the Vitek cards with streptomycin, where it was 96%. Isolates that showed resistance on the streptomycin agar screen plates were rescreened on plates containing 32,000 micrograms/ml to detect ribosomally mediated resistance. For all three systems, every failure to detect streptomycin high-level resistance occurred in isolates with enzymatic, not ribosomal, resistance. The modified MicroScan Type 5 panels are a suitable method for detecting enterococcal high-level resistance to gentamicin and streptomycin. The Vitek cards are too insensitive for this purpose.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1907609      PMCID: PMC269975          DOI: 10.1128/jcm.29.6.1232-1235.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Species identities of enterococci isolated from clinical specimens.

Authors:  K L Ruoff; L de la Maza; M J Murtagh; J D Spargo; M J Ferraro
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

2.  Comparison of four methods for testing high-level aminoglycoside resistance in enterococci.

Authors:  P Yagupsky; S Petry; M A Menegus
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

3.  Evaluation of a commercial microtiter system (MicroScan) using both frozen and freeze-dried panels for detection of high-level aminoglycoside resistance in Enterococcus spp.

Authors:  S A Fuller; D E Low; A E Simor
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

4.  Enterococcal bacteremia: analysis of 75 episodes.

Authors:  R M Gullberg; S R Homann; J P Phair
Journal:  Rev Infect Dis       Date:  1989 Jan-Feb

Review 5.  The life and times of the Enterococcus.

Authors:  B E Murray
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

6.  The prevalence of high-level aminoglycoside resistance among enterococci isolated from blood cultures during 1980-1988.

Authors:  C Watanakunakorn
Journal:  J Antimicrob Chemother       Date:  1989-07       Impact factor: 5.790

Review 7.  The enterococcus: "putting the bug in our ears".

Authors:  S A Hoffmann; R C Moellering
Journal:  Ann Intern Med       Date:  1987-05       Impact factor: 25.391

8.  Group D enterococcal meningitis. Clinical and therapeutic considerations with report of three cases and review of the literature.

Authors:  A S Bayer; J S Seidel; T T Yoshikawa; B F Anthony; L B Guze
Journal:  Arch Intern Med       Date:  1976-08

9.  High-level aminoglycoside-resistant enterococci. Colonization of nursing home and acute care hospital patients.

Authors:  M J Zervos; M S Terpenning; D R Schaberg; P M Therasse; S V Medendorp; C A Kauffman
Journal:  Arch Intern Med       Date:  1987-09

10.  High-level resistance to gentamicin in clinical isolates of enterococci.

Authors:  B D Mederski-Samoraj; B E Murray
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

View more
  8 in total

1.  Comparison of microscan broth microdilution, synergy quad plate agar dilution, and disk diffusion screening methods for detection of high-level aminoglycoside resistance in enterococcus species.

Authors:  David R Murdoch; Stanley Mirrett; Lizzie J Harrell; Susan M Donabedian; Marcus J Zervos; L Barth Reller
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

2.  Factors influencing determination of high-level aminoglycoside resistance in Enterococcus faecalis.

Authors:  D F Sahm; S Boonlayangoor; P C Iwen; J L Baade; G L Woods
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

Review 3.  Expert systems in clinical microbiology.

Authors:  Trevor Winstanley; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

4.  Multicenter laboratory evaluation of the bioMérieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  G V Doern; A B Brueggemann; R Perla; J Daly; D Halkias; R N Jones; M A Saubolle
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

5.  Detection of high-level aminoglycoside resistance in enterococci other than Enterococcus faecalis.

Authors:  D F Sahm; S Boonlayangoor; J E Schulz
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

6.  Evaluation of MicroScan rapid panels for detection of high-level aminoglycoside resistance in enterococci.

Authors:  G L Woods; B DiGiovanni; M Levison; P Pitsakis; D LaTemple
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

7.  Multilaboratory evaluation of screening methods for detection of high-level aminoglycoside resistance in enterococci. National Committee for Clinical Laboratory Standards Study Group on Enterococci.

Authors:  J M Swenson; M J Ferraro; D F Sahm; N C Clark; D H Culver; F C Tenover
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

8.  Susceptibility testing of clinical isolates of Enterococcus faecium and Enterococcus faecalis.

Authors:  M Louie; A E Simor; S Szeto; M Patel; B Kreiswirth; D E Low
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.